Donate to MSK this Giving Tuesday and DOUBLE your impact
December 2 is Giving Tuesday, and the MSK Giving community is coming together to create more hope and possibility for every person with cancer. Help us meet our goal of 5,000 gifts by making a donation to MSK — and get matched!
United by one mission
As part of the MSK Giving community, you are 1 of more than 400,000 people representing 50 states, 87 countries, and 5 continents. What brings us all together? Our commitment to supporting MSK’s mission of ending cancer for life.
So we can build a brighter future for every person with cancer
Your support this Giving Tuesday allows MSK to continue setting the global standard for cancer care. Together, everyone who’s a part of MSK — researchers, clinicians, staff, and the MSK Giving community — can help power breakthroughs that lead to new cures and bring more hope to patients and their families.
Today and every day, MSK donors make a real difference
When you donate to MSK for Giving Tuesday, you’re not just supporting any cancer charity. You’re backing one of the world’s leading authorities in cancer research, care, and education. The discoveries made by MSK doctors and scientists, supported by you, transform the way patients are treated worldwide.
Defying the odds
An immunotherapy clinical trial at MSK saw rectal cancer disappear in 100% of people who took part. The drug, dostarlimab (Jemperli®), received FDA Breakthrough Therapy designation last year, bringing it closer to people who need it.
Read about the breakthroughInnovating to stop recurrence
For many patients with stomach and esophageal cancer, standard chemotherapy isn’t enough to stop the cancer from coming back. MSK doctors showed that adding immunotherapy improved outcomes, helping people live cancer-free for longer.
Get the full storyCombating treatment resistance
A new three-drug combination for people with ER-positive, HER2-negative breast cancer extended survival by an average of seven months, offering hope for a new treatment option for patients with treatment-resistant disease.
Dive deeperLeading new discoveries
MSK researchers presented promising results on three different targeted therapies for lung cancer at the 2025 American Society of Clinical Oncology Annual Meeting.
Learn more about the advancesPioneering programs
MSK’s Exercise Oncology Program is showing how exercise benefits cancer care — not only by counteracting the harsh physical side effects of some treatments but also by altering the biology of people’s tumors.
Take a closer look
More than six years after being diagnosed with brain cancer, Brian has no signs of recurrence — thanks to his treatment at MSK. He joined MSK’s official running program, Fred’s Team, to support MSK.
More than six years after being diagnosed with brain cancer, Brian has no signs of recurrence — thanks to his treatment at MSK. He joined MSK’s official running program, Fred’s Team, to support MSK.
Double your impact on cancer research at MSK this Giving Tuesday
